A Look At Benzinga Pro's Most-Searched Tickers For June 17

Loading...
Loading...

This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform.

  1. ContraVir Pharmaceuticals CTRV shares were up 40% to $12.37. The company reported positive results from human liver experiments with its NASH drug candidate.
  2. Array BioPharma Inc ARRY shares were up 55% to $46 after the company announced it would be acquired by Pfizer for $48 per share in cash.
  3. ArQule, Inc ARQL shares were up 15% to $9.45. The company announced preliminary results from its Phase 1/2 study of miransertib in patients with PIKCA-3CA-related Overgrowth Spectrum and Proteus syndrome in an Oral Presentation at the European Society of Human Genetics Conference
  4. Dare Biosciences, Inc DARE shares were 11% to 99 cents after the company reported results from its thermography study of sildenafil showed "the utility of thermography technology to detect statistically meaningful differences in genital temperature changes."
  5. VBI Vaccines Inc VBIV shares were down 61% after the company reported results from its Phase 3 study of Sci-B-Vac. The trial met both co-primary endpoints but did not meet its secondary objective on non-inferiority.
  6. Facebook Inc FB shares were up 2.9% to $186.50. The stock has experienced continued momentum since it signed up several companies to back its new cryptocurrency.
  7. Riot Blockchain RIOT shares were up 4.7% to $2.86.
  8. Beyond Meat BYND shares were up 12% to $169.79. The company has experienced continued volatility since its IPO.
  9. Energy Focus Inc EFOI shares were up 15% at 50 cents.
  10. ReWalk Robotics RWLK shares were up 2.7% to $5.35 after H.C. Wainwright upgraded the stock from Neutral to Buy and raised the price target from $4 to $9.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: CryptocurrencyNewsIntraday UpdateMarketsTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...